

<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>

</head>

<body>

    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141640467475000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201905020%26RESULT%3d1%26SIGN%3deZobn0iIFSPMPzu10jUSRTsQsO0%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905020&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905020&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>


    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905020&amp;v=MjkxNzdJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdOUFRYTVpiRzRIOWpNcW85SFo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#36" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#37" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#40" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#42" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#44" data-title="1.4 评估标准">1.4 评估标准</a></li>
                                                <li><a href="#47" data-title="1.5 统计学处理">1.5 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#49" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#50" data-title="2.1 临床疗效">2.1 临床疗效</a></li>
                                                <li><a href="#53" data-title="2.2 血脂指标">2.2 血脂指标</a></li>
                                                <li><a href="#56" data-title="2.3 血压与动脉功能">2.3 血压与动脉功能</a></li>
                                                <li><a href="#59" data-title="2.4 不良反应">2.4 不良反应</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#61" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#52" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组临床疗效比较&lt;/b&gt;(n=56)"><b>表</b>1 <b>两组临床疗效比较</b>(n=56)</a></li>
                                                <li><a href="#55" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;治疗前后两组血脂对比&lt;/b&gt;&lt;mathml id=&quot;67&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;,&lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mn&gt;6&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>治疗前后两组血脂对比</b><mathml id="67"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                                <li><a href="#58" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;治疗前后两组血压与动脉功能指标对比&lt;/b&gt;&lt;mathml id=&quot;68&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>治疗前后两组血压与动脉功能指标对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="王罗卿,孙黎明,王怡练,等.瑞舒伐他汀与阿托伐他汀对冠心病患者血清脂肪因子Vaspin的影响[J].实用医学杂志,2015,31(2):289-291." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201502050&amp;v=MDM0MDl1Wm1GeW5oVnI3TU5qVFNkTEc0SDlUTXJZOUFaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        王罗卿,孙黎明,王怡练,等.瑞舒伐他汀与阿托伐他汀对冠心病患者血清脂肪因子Vaspin的影响[J].实用医学杂志,2015,31(2):289-291.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="张理科,陈宇.瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效和安全性比较[J].中国药房,2016,27(12):1611-1613." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201612011&amp;v=MTU2MjlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNUHlyU2I3RzRIOWZOclk5RVpZUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        张理科,陈宇.瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效和安全性比较[J].中国药房,2016,27(12):1611-1613.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="孙平,侯东彬,邱静,等.瑞舒伐他汀与阿托伐他汀对早发冠心病急性心肌梗死患者血管内皮功能和心脏功能的影响[J].基因组学与应用生物学,2016,35(8):1893-1898." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXNB201608016&amp;v=MDUxMTdvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNSWpYRmJMRzRIOWZNcDQ5RVk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        孙平,侯东彬,邱静,等.瑞舒伐他汀与阿托伐他汀对早发冠心病急性心肌梗死患者血管内皮功能和心脏功能的影响[J].基因组学与应用生物学,2016,35(8):1893-1898.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="方利华.瑞舒伐他汀对冠心病合并高脂血症老年患者血脂水平和炎症因子影响的临床研究[J].中国现代医学杂志,2014,24(36):43-46." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201436010&amp;v=MjMxNTVoVnI3TVB6WFBkN0c0SDlYUHFZOUVaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW4=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        方利华.瑞舒伐他汀对冠心病合并高脂血症老年患者血脂水平和炎症因子影响的临床研究[J].中国现代医学杂志,2014,24(36):43-46.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Jackowska P,Pytel E,Koter-Michalak M,et al.The effect of combined ezetimibe/atorvastatin therapy vs.atorvastatin monotherapy on the erythrocyte membrane structure in patients with coronary artery disease:a pilot study[J].Adv Clin Exp Med,2016,25(3):433-439." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The Effect of Combined Ezetimibe/Atorvastatin Therapy vs.Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease:A Pilot Study">
                                        <b>[5]</b>
                                        Jackowska P,Pytel E,Koter-Michalak M,et al.The effect of combined ezetimibe/atorvastatin therapy vs.atorvastatin monotherapy on the erythrocyte membrane structure in patients with coronary artery disease:a pilot study[J].Adv Clin Exp Med,2016,25(3):433-439.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Arbab-Zadeh A,Fuster V.The myth of the &quot;vulnerable plaque&quot;:transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment [J].J Am Coll Cardiol,2015,65(8):846-855." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The myth of the&amp;quot;vulnerable plaque&amp;quot;:transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment">
                                        <b>[6]</b>
                                        Arbab-Zadeh A,Fuster V.The myth of the &quot;vulnerable plaque&quot;:transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment [J].J Am Coll Cardiol,2015,65(8):846-855.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-742." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGGZ201108003&amp;v=Mjc2OTh0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNUHlyTWRMRzRIOURNcDQ5Rlo0UUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-742.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Smith SC Jr,Benjamin EJ,Bonow RO,et al.AHA/ACCF secondary prevention and risk reduction therapy forpatients with coronary and other atherosclerotic vasculardisease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association[J].J Am Coll Cardiol,2011,58(23):2432-2346." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=AHA/ACCF secondary prevention and risk reduction therapy forpatients with coronary and other atherosclerotic vasculardisease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World He">
                                        <b>[8]</b>
                                        Smith SC Jr,Benjamin EJ,Bonow RO,et al.AHA/ACCF secondary prevention and risk reduction therapy forpatients with coronary and other atherosclerotic vasculardisease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association[J].J Am Coll Cardiol,2011,58(23):2432-2346.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="杨涛,冯现君,赵娟,等.氨氯地平瑞舒伐他汀钙片对高血压合并冠心病患者临床效果以及炎症的影响研究[J].中国医学创新,2015,12(25):137-139." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYCX201525047&amp;v=MjkzNzdCdEdGckNVUjdxZlp1Wm1GeW5oVnI3TVB6VElkckc0SDlUT3FvOUJZNFFLREg4NHZSNFQ2ajU0TzN6cXE=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        杨涛,冯现君,赵娟,等.氨氯地平瑞舒伐他汀钙片对高血压合并冠心病患者临床效果以及炎症的影响研究[J].中国医学创新,2015,12(25):137-139.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="王鹏,严妍,于文君,等.阿托伐他汀与瑞舒伐他汀对冠心病患者的疗效与安全性对比观察[J].中国医院药学杂志,2018,38(2):169-172,202." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201802014&amp;v=MTA3ODNVUjdxZlp1Wm1GeW5oVnI3TVB5clNkTEc0SDluTXJZOUVZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        王鹏,严妍,于文君,等.阿托伐他汀与瑞舒伐他汀对冠心病患者的疗效与安全性对比观察[J].中国医院药学杂志,2018,38(2):169-172,202.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="姚立军,陈弹.瑞舒伐他汀与阿托伐他汀对冠心病患者血脂、动脉粥样硬化程度和血管内皮舒张功能的疗效对比[J].中国药房,2017,28(35):4963-4966." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201735018&amp;v=MjY1MjF5clNiN0c0SDliUHFvOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVnI3TVA=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        姚立军,陈弹.瑞舒伐他汀与阿托伐他汀对冠心病患者血脂、动脉粥样硬化程度和血管内皮舒张功能的疗效对比[J].中国药房,2017,28(35):4963-4966.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="Rajendra Reddy G,Ravindra Reddy P,Siva Jyothi P.Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach[J].Sci Pharm,2015,83(2):279-296." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach">
                                        <b>[12]</b>
                                        Rajendra Reddy G,Ravindra Reddy P,Siva Jyothi P.Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach[J].Sci Pharm,2015,83(2):279-296.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="Chen QJ,Lai HM,Chen BD,et al.Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang,China[J]Inter J Envir Res Pub Health,2016,13(2):235." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang,China">
                                        <b>[13]</b>
                                        Chen QJ,Lai HM,Chen BD,et al.Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang,China[J]Inter J Envir Res Pub Health,2016,13(2):235.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="黄涛,曾恋,田井强,等.瑞舒伐他汀治疗老年冠心病合并高脂血症的机制研究[J].重庆医学,2016,45(20):2801-2803." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201620024&amp;v=MzAzMDRkckc0SDlmT3I0OUhZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVnI3TUpqelM=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        黄涛,曾恋,田井强,等.瑞舒伐他汀治疗老年冠心病合并高脂血症的机制研究[J].重庆医学,2016,45(20):2801-2803.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="潘力健,龚辉,王昕.瑞舒伐他汀对内皮细胞功能变化的影响[J].中国药房,2015,26(29):4069-4072." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201529014&amp;v=MjQyMTlHRnJDVVI3cWZadVptRnluaFZyN01QeXJTYjdHNEg5VE9wbzlFWUlRS0RIODR2UjRUNmo1NE8zenFxQnQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        潘力健,龚辉,王昕.瑞舒伐他汀对内皮细胞功能变化的影响[J].中国药房,2015,26(29):4069-4072.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(05),639-643 DOI:10.3969/j.issn.1008-0074.2019.05.20            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>瑞舒伐他汀治疗冠心病合并高血压患者的临床疗效及对血脂的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%B4%94%E7%8E%89%E5%8D%8E&amp;code=31458047&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">崔玉华</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B1%9F%E8%8B%8F%E7%9C%81%E5%93%8D%E6%B0%B4%E5%8E%BF%E4%B8%AD%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0171159&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">江苏省响水县中医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察瑞舒伐他汀治疗冠心病合并高血压患者的临床疗效及对血脂的影响。<b>方法</b>:本院收治的112例高血压合并冠心病患者被随机均分为常规治疗组与瑞舒伐他汀组;治疗3个月后,评估两组临床疗效,比较治疗前后两组患者血脂、血压、动脉功能的变化情况及不良反应发生率。<b>结果</b>:瑞舒伐他组总有效率显著高于常规治疗组(92.86%比78.57%,<i>P</i>=0.031)。治疗3个月后,与常规治疗组比较,瑞舒伐他组血清TC[(4.18±0.96)mmol/L比(3.21±0.87)mmol/L]、TG[(1.68±0.54)mmol/L比(1.31±0.51)mmol/L]、LDL-C[(2.06±0.81)mmol/L比(1.64±0.76)mmol/L]水平,血压[(140.77±10.36)/(82.94±8.87)mmHg比(124.23±9.48)/(72.49±7.56)mmHg]及动脉斑块积分[(4.36±0.71)分比(4.08±0.67)分]显著降低,HDL-C[(1.36±0.41)mmol/L比(1.68±0.49)mmol/L]水平、肱动脉血流介导的舒张功能(FMD)[(7.36±0.98)%比(8.59±1.06)%]显著提高(<i>P</i>&lt;0.05或&lt;0.01)。两组不良反应无统计学差异(<i>P</i>=0.487)。<b>结论</b>:瑞舒伐他汀治疗冠心病合并高血压疗效理想,能够显著改善患者血脂、血压水平及动脉功能。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E5%BF%83%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠心病;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%AB%98%E8%A1%80%E5%8E%8B&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">高血压;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%AB%98%E8%84%82%E8%A1%80%E7%97%87&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">高脂血症;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%91%9E%E8%88%92%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">瑞舒伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-04-13</p>

            </div>
                    <h1>Therapeutic effect of rosuvastatin on patients with coronary heart disease complicated hypertension and its impact on blood lipids</h1>
                    <h2>
                    <span>CUI Yu-hua</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Traditional Chinese Medicine Hospital of Xiangshui County</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To observe therapeutic effect of rosuvastatin on patients with coronary heart disease(CHD) complicated hypertension(EH) and its impact on blood lipids etc. <b>Methods</b>: A total of 112 CHD + EH patients treated in our hospital were randomly and equally divided into routine treatment group and rosuvastatin group. After three-month treatment, therapeutic effect was assessed, levels of blood lipids, blood pressure and incidence rate of adverse reactions were compared between two groups before and after treatment. <b>Results</b>: Total effective rate of rosuvastatin group was significantly higher than that of routine treatment group(92.86%vs. 78.57%, <i>P</i>=0.031). After three-month treatment, compared with routine treatment group, there were significant reductions in serum levels of TC[(4.18±0.96)mmol/Lvs.(3.21±0.87)mmol/L], TG[(1.68±0.54)mmol/Lvs.(1.31±0.51)mmol/L],LDL-C[(2.06±0.81)mmol/Lvs.(1.64±0.76)mmol/L], blood pressure [(140.77±10.36)/(82.94±8.87)mmHgvs.(124.23±9.48)/(72.49±7.56)mmHg]and arterial plaque score [(4.36±0.71)scores vs.(4.08±0.67)scores], and significant rise in HDL level [(1.36±0.41)mmol/Lvs.(1.68±0.49)mmol/L]and fore brachial artery endothelium dependent diastolic-systolic function(FMD) [(7.36±0.98)% vs.(8.59±1.06)%]in rosuvastatin group, <i>P</i>&lt;0.05 or &lt;0.01.There was no significant difference in incidence rate of adverse reactions between two groups, <i>P</i>=0.487.<b>Conclusion</b>: Rosuvastatin possesses significant therapeutic effect on CHD + EH. It can significantly improve levels of blood lipids and blood pressure and arterial function in these patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20disease&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary disease;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Hypertension&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Hypertension;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Hyperlipidemias&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Hyperlipidemias;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Rosuvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Rosuvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-04-13</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="35">冠心病是由于脂代谢紊乱,使得血液中脂质含量过高,加之血糖、血小板异常凝集等因素共同作用下使血流速减慢而导致血液中脂质不断地沉积于动脉内膜,致使脂质斑块形成导致动脉管腔狭窄或阻塞,而诱发的一系列心脏缺血、缺氧性病变<citation id="69" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>。随着我国人民收入水平的不断提高,日常饮食结构中脂质摄入量显著上升,在吸烟等不良生活习惯、运动量减少等诸多不良因素的共同作用下,导致我国高血压的发生率呈现出明显上升且有年轻化趋势。高血压如未能给予及时有效的治疗,可损伤患者的各级血管及各组织器官,临床上较为常见的包括心血管、肾功能、脑组织等的损伤,重症者可见组织脏器的功能衰竭<citation id="70" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><link href="15" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>,<a class="sup">6</a>]</sup></citation>。当血流速减低时机体通过增加血压而完成供血需要,因此高血压与冠心病具有同质性致病基础。两者常合并发生,而高血压合并冠心病时,则极大地增加了疾病的危险性,因此应给予及时有效的治疗,以预防心脑血管意外的发生。近年来,瑞舒伐他汀的应用逐渐普及,为了客观评估其在高血压合并冠心病治疗中的功效,本院特开展本次研究。现将具体研究情况于后文中作详细阐述。</p>
                </div>
                <h3 id="36" name="36" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="37" name="37">1.1 一般资料</h4>
                <div class="p1">
                    <p id="38">选择本院2015年1月～2017年12月间收治的112例患者作为本次研究资料,依据随机数字表法,入选患者被均分为常规治疗组与瑞舒伐他汀组,每组各56例。常规治疗组中男24例,女32例,年龄45～76(61.26±8.12)岁;高血压病程2～8(4.62±1.13)年;冠心病病程1～4(2.64±0.89)年。瑞舒伐他汀组中男26例,女30例,年龄44～78(61.29±8.19)岁;高血压病程2～9(4.68±1.15)年;冠心病病程1～5(2.67±0.91)年。两组患者的一般资料无统计学差异,<i>P</i>均&gt;0.05。</p>
                </div>
                <div class="p1">
                    <p id="39">诊断标准:高血压依据《中国高血压防治指南2010》标准诊断,冠心病依据2011年美国心脏协会/美国心脏病学院基金会(AHA/ACCF)所制定的《冠心病和其他AS性血管病患者的二级预防及降低风险治疗指南》中关于冠心病的相关标准诊断<citation id="71" type="reference"><link href="17" rel="bibliography" /><link href="19" rel="bibliography" /><sup>[<a class="sup">7</a>,<a class="sup">8</a>]</sup></citation>。纳入标准:①均同时符合上述诊断标准;②经本院心电图、彩色多普勒超声、冠状动脉CT等医学影像学检查后确诊;③患者在了解本次研究内容后自愿入组,并签署知情同意书。排除标准:①合并肝、肾功能不全的患者;②心脑血管意外急性期患者;③合并恶性肿瘤的患者;④合并心脏其他疾病以及先天性结构异常或先天性心脏病的患者;⑤合并心功能、肾功能衰竭的患者;⑥对于本次研究所涉及的药物有过敏史的患者。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="41">常规治疗组采取常规治疗,控制饮食、适量运动、监测控制血糖以及对症治疗。同时,给予氨氯地平片(辉瑞制药有限公司出品,国药准字H10950224),初始计量5mg/次,1次/d,视患者血脂、血压情况可增加至10mg/次,1次/d,口服,连续治疗3个月为1疗程。瑞舒伐他汀组在常规治疗组上述用药的同时,给予瑞舒伐他汀钙片(南京正大天晴制药有限公司出品,国药准字 H20080669)10mg/次,1次/晚,口服,连续治疗3个月为1疗程。</p>
                </div>
                <h4 class="anchor-tag" id="42" name="42">1.3 观察指标</h4>
                <div class="p1">
                    <p id="43">治疗1疗程后,评估两组临床疗效,瑞舒伐他汀组治疗前后两组患者血脂:总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白-胆固醇(HDL-C)和低密度脂蛋白-胆固醇(LDL-C),血压:收缩压、舒张压,动脉功能指标:肱动脉血流介导的舒张功能(FMD)、颈动脉内膜中层厚度(IMT)、动脉斑块积分(Crouse)的变化情况;同时观察两组用药不良反应发生率。</p>
                </div>
                <h4 class="anchor-tag" id="44" name="44">1.4 评估标准</h4>
                <div class="p1">
                    <p id="45">临床疗效依据相关文献评估<citation id="72" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。以舒张压达正常范围,收缩压降低&gt;10mmHg,心绞痛、胸闷、胸痛等冠心病主要症状显著改善为显效;以收缩压或舒张压降低&gt;10mmHg,但未达正常范围,上述冠心病主要症状有所改善为有效;以未达上述标准或较治疗前有所加重为无效;总有效为显效、有效的合计。</p>
                </div>
                <div class="p1">
                    <p id="46">动脉功能使用彩色多普勒超声检测。采集两组患者治疗前后的空腹外周静脉血样3ml,使用离心机分离血清后,使用全自动生化分析仪检测各项血脂指标。Crouse积分为各斑块厚度的总和,积分越高说明斑块程度越严重。</p>
                </div>
                <h4 class="anchor-tag" id="47" name="47">1.5 统计学处理</h4>
                <div class="p1">
                    <p id="48">使用SPSS 21.0软件进行统计学分析。符合正态分布的计量资料以均数±标准差<mathml id="66"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml>表示,比较采用<i>t</i>检验,计数资料以百分率表示,比较采用<i>χ</i><sup>2</sup>检验。等级资料使用非参数分析,计数资料使用卡方检验,均以n(%)描述。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="49" name="49" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="50" name="50">2.1 临床疗效</h4>
                <div class="p1">
                    <p id="51">瑞舒伐他汀组总有效率与整体疗效均显著优于常规治疗组,<i>P</i>均&lt;0.05;见表1。</p>
                </div>
                <div class="area_img" id="52">
                    <p class="img_tit"><b>表</b>1 <b>两组临床疗效比较</b>(n=56) <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="52" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i>(%)</td><td>有效<br /><i>n</i>(%)</td><td>无效<br /><i>n</i>(%)</td><td>总有效率<br /><i>n</i>(%)</td></tr><tr><td><br />常规治疗组</td><td>31(55.36)</td><td>13(23.21)</td><td>12(21.43)</td><td>44(78.57)</td></tr><tr><td><br />瑞舒伐他汀组</td><td>41(73.21)</td><td>11(19.64)</td><td>4(7.14)</td><td>52(92.86)<sup>△</sup></td></tr><tr><td><br /><i>Z</i>/<i>χ</i><sup>2</sup></td><td></td><td>-2.192</td><td></td><td>4.667</td></tr><tr><td><br /><i>P</i></td><td></td><td>0.028</td><td></td><td>0.031</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与常规治疗组比较△<i>P</i>&lt;0.05,△△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">2.2 血脂指标</h4>
                <div class="p1">
                    <p id="54">治疗前两组各项血脂指标均无统计学差异,<i>P</i>均&gt;0.05;与治疗前比较,治疗后两组TC、TG、LDL-C水平均显著降低,HDL-C水平显著升高(<i>P</i>&lt;0.05或&lt;0.01);且与常规治疗组比较,治疗后瑞舒伐他汀组TC、TG、LDL-C水平降低更显著,HDL-C水平升高更显著(<i>P</i>均&lt;0.01)。见表2。</p>
                </div>
                <div class="area_img" id="55">
                    <p class="img_tit"><b>表</b>2 <b>治疗前后两组血脂对比</b><mathml id="67"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>5</mn><mn>6</mn><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="55" border="1"><tr><td><br />组别</td><td>时间</td><td>总胆固醇<br />(mmol/L)</td><td>甘油三酯<br />(mmol/L)</td><td>高密度脂蛋白-胆固醇<br />(mmol/L)</td><td>低密度脂蛋白-胆固醇<br />(mmol/L)</td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>5.37±1.02</td><td>2.31±0.58</td><td>1.17±0.38</td><td>3.49±0.87</td></tr><tr><td><br /></td><td>治疗后</td><td>4.18±0.96<sup>**</sup></td><td>1.68±0.54<sup>**</sup></td><td>1.36±0.41<sup>*</sup></td><td>2.06±0.81<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>6.358/0.001</td><td>5.949/0.001</td><td>2.543/0.012</td><td>9.002/0.001</td></tr><tr><td><br />瑞舒伐他汀组</td><td>治疗前</td><td>5.39±1.03</td><td>2.33±0.59</td><td>1.15±0.36</td><td>3.52±0.89</td></tr><tr><td><br /></td><td>治疗后</td><td>3.21±0.87<sup>**△△</sup></td><td>1.31±0.51<sup>**△△</sup></td><td>1.68±0.49<sup>**△△</sup></td><td>1.64±0.76<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>12.100/0.001</td><td>9.787/0.001</td><td>6.523/0.001</td><td>12.021/0.001</td></tr><tr><td><br />两组治疗前<i>t</i>/<i>P</i></td><td></td><td>0.103/0.918</td><td>0.181/0.857</td><td>0.286/0.775</td><td>0.180/0.857</td></tr><tr><td><br />两组治疗后<i>t</i>/<i>P</i></td><td></td><td>5.603/0.001</td><td>3.728/0.001</td><td>3.748/0.001</td><td>2.830/0.006</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05,**<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="56" name="56">2.3 血压与动脉功能</h4>
                <div class="p1">
                    <p id="57">治疗前两组血压水平与动脉功能指标均无统计学差异,<i>P</i>均&gt;0.05;治疗后两组收缩压、舒张压均显著降低,FMD显著提高(<i>P</i>均=0.001),治疗后瑞舒伐他汀组Crouse积分显著下降(<i>P</i>=0.004),且与常规治疗组比较,治疗后瑞舒伐他汀组收缩压、舒张压、Crouse积分降低更显著,FMD提高更显著(<i>P</i>&lt;0.05或&lt;0.01)。见表3。</p>
                </div>
                <div class="area_img" id="58">
                    <p class="img_tit"><b>表</b>3 <b>治疗前后两组血压与动脉功能指标对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="58" border="1"><tr><td><br />组别</td><td>时间</td><td>收缩压<br />(mmHg)</td><td>舒张压<br />(mmHg)</td><td>肱动脉扩张<br />(%)</td><td>颈动脉内膜厚度<br />(mm)</td><td>Crouse<br />(分)</td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>159.68±11.24</td><td>98.19±9.62</td><td>6.22±0.91</td><td>1.92±0.79</td><td>4.47±0.76</td></tr><tr><td><br /></td><td>治疗后</td><td>140.77±10.36<sup>**</sup></td><td>82.94±8.87<sup>**</sup></td><td>7.36±0.98<sup>**</sup></td><td>1.88±0.75</td><td>4.36±0.71</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>9.257/0.001</td><td>8.721/0.001</td><td>6.379/0.001</td><td>0.275/0.784</td><td>0.791/0.430</td></tr><tr><td><br />瑞舒伐他汀组</td><td>治疗前</td><td>159.76±11.28</td><td>98.23±9.65</td><td>6.19±0.89</td><td>1.95±0.81</td><td>4.49±0.79</td></tr><tr><td><br /></td><td>治疗后</td><td>124.23±9.48<sup>**△△</sup></td><td>72.49±7.56<sup>**△△</sup></td><td>8.59±1.06<sup>**△△</sup></td><td>1.79±0.72</td><td>4.08±0.67<sup>**△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>18.045/0.001</td><td>15.713/0.001</td><td>12.976/0.001</td><td>1.105/0.272</td><td>2.962/0.004</td></tr><tr><td><br />两组治疗前<i>t</i>/<i>P</i></td><td></td><td>0.038/0.970</td><td>0.022/0.983</td><td>0.176/0.860</td><td>0.198/0.843</td><td>0.137/0.892</td></tr><tr><td><br />两组治疗后<i>t</i>/<i>P</i></td><td></td><td>8.814/0.001</td><td>6.710/0.001</td><td>6.376/0.001</td><td>0.648/0.518</td><td>2.146/0.034</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:Crouse:动脉斑块积分。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="59" name="59">2.4 不良反应</h4>
                <div class="p1">
                    <p id="60">治疗期间两组均未见严重不良反应,常规治疗组中2例头晕、1例恶心,不良反应总发生率为5.36%(3/56),瑞舒伐他汀组中头晕2例、2例恶心、2例嗜睡,不良反应总发生率为10.71%(6/56),两组不良反应无统计学差异,<i>χ</i><sup>2</sup>=0.483,<i>P</i>=0.487。</p>
                </div>
                <h3 id="61" name="61" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="62">冠心病是临床上一种较为常见的心脑血管系统疾病。主要可见胸骨后方绞痛,可向左上肢、左肩放射,持续时间通常较短约为1～5min,通过休息及含服硝酸酯类的药物多可缓解<citation id="73" type="reference"><link href="21" rel="bibliography" /><link href="23" rel="bibliography" /><link href="25" rel="bibliography" /><sup>[<a class="sup">9</a>,<a class="sup">10</a>,<a class="sup">11</a>]</sup></citation>。劳累、寒冷刺激、饱餐等为本病的主要突发诱因。冠心病如未能得到及时有效的治疗,可诱发心肌梗死、动脉栓塞等危重症而危及患者的生命安全<citation id="74" type="reference"><link href="27" rel="bibliography" /><link href="29" rel="bibliography" /><link href="31" rel="bibliography" /><sup>[<a class="sup">12</a>,<a class="sup">13</a>,<a class="sup">14</a>]</sup></citation>。高血压在我国是一种十分常见的心脑血管系统疾病,其形成与演进与运动量小、饮食脂含量过高、吸烟、嗜酒、遗传因素、年龄增长以及环境因素等相关。高血压患者可见头痛、头晕、失眠、乏力、胸闷等主要临床表现,重症者可见肾功能损伤以及脏器功能衰竭等表现。血脂的异常升高是冠心病与高血压形成的重要基础,多数冠心病患者可合并有高血压,高血压是冠心病的一种较为常见的合并症,而一旦两种疾病合并发生时则可增加疾病的危险性。</p>
                </div>
                <div class="p1">
                    <p id="63">氨氯地平与瑞舒伐他汀均为临床常用药物,在高血压合并冠心病的临床治疗中具有确切疗效。氨氯地平能够有效松弛血管平滑肌,降低外周血管阻力,因此具有确切降低血压的作用。他汀类药物具有较好的调节血脂功效,能够有效降低血脂水平,减少血管内皮的脂质沉淀,因此可发挥延缓动脉硬化形成的功效。瑞舒伐他汀是第三代的他汀类药物,在调节血脂方面的作用更加显著。瑞舒伐他汀可有效减少血管内脂质的沉淀,在延缓冠心病进展方面具有一定临床价值。另外,有研究表明,瑞舒伐他汀还具有一定的抗炎作用,能够改善血管的内皮功能,抑制血管平滑肌的异常增殖。</p>
                </div>
                <div class="p1">
                    <p id="64">本次研究结果表明,瑞舒伐他汀组给予瑞舒伐他汀治疗后,临床总有效率与整体疗效水平均显著高于常规治疗组;充分证明了瑞舒伐他汀能够有效提高冠心病合并高血压患者的临床疗效。由于两种疾病均以血脂异常升高为基础,使得在疾病的治疗控制过程中,对于血脂的治疗尤为重要。因此,本次研究中我们对两组患者的血脂水平进行了对比观察,结果表明治疗后两组患者的血脂水平均有所改善,但瑞舒伐他汀组患者血脂水平均显著优于常规治疗组,提示瑞舒伐他汀具有理想的降脂作用。治疗后瑞舒伐他汀组患者的收缩压、舒张压均显著低于常规治疗组,提示应用瑞舒伐他汀后能够有效增强降低血压的功效。FMD、Crouse积分、IMT对于明确患者脂质斑块情况、评估心脑血管意外风险等均具有重要的参考价值。治疗后瑞舒伐他汀组动脉功能指标与常规治疗组比较,FMD显著提高、Crouse积分显著降低,提示瑞舒伐他汀具有改善血管内皮细胞功能、增强肱动脉扩张功能的作用。这一研究结果与潘力健等人的研究结果相符<citation id="75" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。但两组IMT未见统计学差异,我们认为提示瑞舒伐他汀在溶解已形成的颈动脉狭窄方面尚无明确功效。两组治疗过程中的不良反应发生率无统计学差异,提示应用瑞舒伐他汀安全可靠,不会增加临床不良反应发生风险。</p>
                </div>
                <div class="p1">
                    <p id="65">综上所述,瑞舒他汀治疗冠心病合并高血压疗效理想,可有效降低患者血脂与血压水平,从而降低心脑血管意外的发生风险,延缓冠心病、高血压病情进展。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201502050&amp;v=MjcwNDRSN3FmWnVabUZ5bmhWcjdNTmpUU2RMRzRIOVRNclk5QVpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>王罗卿,孙黎明,王怡练,等.瑞舒伐他汀与阿托伐他汀对冠心病患者血清脂肪因子Vaspin的影响[J].实用医学杂志,2015,31(2):289-291.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201612011&amp;v=MTQ2MDBESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNUHlyU2I3RzRIOWZOclk5RVpZUUs=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>张理科,陈宇.瑞舒伐他汀与阿托伐他汀治疗冠心病的疗效和安全性比较[J].中国药房,2016,27(12):1611-1613.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GXNB201608016&amp;v=MDE2MTZWcjdNSWpYRmJMRzRIOWZNcDQ5RVlvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmg=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>孙平,侯东彬,邱静,等.瑞舒伐他汀与阿托伐他汀对早发冠心病急性心肌梗死患者血管内皮功能和心脏功能的影响[J].基因组学与应用生物学,2016,35(8):1893-1898.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201436010&amp;v=MDEzNTZxQnRHRnJDVVI3cWZadVptRnluaFZyN01QelhQZDdHNEg5WFBxWTlFWklRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>方利华.瑞舒伐他汀对冠心病合并高脂血症老年患者血脂水平和炎症因子影响的临床研究[J].中国现代医学杂志,2014,24(36):43-46.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The Effect of Combined Ezetimibe/Atorvastatin Therapy vs.Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease:A Pilot Study">

                                <b>[5]</b>Jackowska P,Pytel E,Koter-Michalak M,et al.The effect of combined ezetimibe/atorvastatin therapy vs.atorvastatin monotherapy on the erythrocyte membrane structure in patients with coronary artery disease:a pilot study[J].Adv Clin Exp Med,2016,25(3):433-439.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The myth of the&amp;quot;vulnerable plaque&amp;quot;:transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment">

                                <b>[6]</b>Arbab-Zadeh A,Fuster V.The myth of the "vulnerable plaque":transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment [J].J Am Coll Cardiol,2015,65(8):846-855.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGGZ201108003&amp;v=MTg1MTMzenFxQnRHRnJDVVI3cWZadVptRnluaFZyN01QeXJNZExHNEg5RE1wNDlGWjRRS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-742.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="http://scholar.cnki.net/result.aspx?q=AHA/ACCF secondary prevention and risk reduction therapy forpatients with coronary and other atherosclerotic vasculardisease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World He">

                                <b>[8]</b>Smith SC Jr,Benjamin EJ,Bonow RO,et al.AHA/ACCF secondary prevention and risk reduction therapy forpatients with coronary and other atherosclerotic vasculardisease:2011 update:a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association[J].J Am Coll Cardiol,2011,58(23):2432-2346.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYCX201525047&amp;v=MDg3MTFPcW85Qlk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNUHpUSWRyRzRIOVQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>杨涛,冯现君,赵娟,等.氨氯地平瑞舒伐他汀钙片对高血压合并冠心病患者临床效果以及炎症的影响研究[J].中国医学创新,2015,12(25):137-139.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201802014&amp;v=MTc1NDFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFZyN01QeXJTZExHNEg5bk1yWTlFWUlRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>王鹏,严妍,于文君,等.阿托伐他汀与瑞舒伐他汀对冠心病患者的疗效与安全性对比观察[J].中国医院药学杂志,2018,38(2):169-172,202.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201735018&amp;v=MTgwMDk5YlBxbzlFYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFZyN01QeXJTYjdHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>姚立军,陈弹.瑞舒伐他汀与阿托伐他汀对冠心病患者血脂、动脉粥样硬化程度和血管内皮舒张功能的疗效对比[J].中国药房,2017,28(35):4963-4966.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach">

                                <b>[12]</b>Rajendra Reddy G,Ravindra Reddy P,Siva Jyothi P.Development of a Stability-Indicating Stereoselective Method for Quantification of the Enantiomer in the Drug Substance and Pharmaceutical Dosage Form of Rosuvastatin Calcium by an Enhanced Approach[J].Sci Pharm,2015,83(2):279-296.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang,China">

                                <b>[13]</b>Chen QJ,Lai HM,Chen BD,et al.Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang,China[J]Inter J Envir Res Pub Health,2016,13(2):235.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201620024&amp;v=MjM2NDhIOWZPcjQ5SFlJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdNSmp6U2RyRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>黄涛,曾恋,田井强,等.瑞舒伐他汀治疗老年冠心病合并高脂血症的机制研究[J].重庆医学,2016,45(20):2801-2803.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201529014&amp;v=MDAzNzBUT3BvOUVZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVnI3TVB5clNiN0c0SDk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>潘力健,龚辉,王昕.瑞舒伐他汀对内皮细胞功能变化的影响[J].中国药房,2015,26(29):4069-4072.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201905020" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>


    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905020&amp;v=MjkxNzdJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhWcjdOUFRYTVpiRzRIOWpNcW85SFo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>


    <link href="/kxreader/Content/css/LeftDetail?v=vAscMyvIPP9NePnbGPkqJ0A5tHOvnzl65tGuRDsf9xg1" rel="stylesheet"/>

</body>
</html>

